Home › NDC Lookup › Ingredients › Pyrantel Pamoate › 73581-0113-12
PINRID Pyrantel Pamoate 250 mg Tablet, 12-count — NDC 73581-0113-12 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

PINRID Pyrantel Pamoate 250 mg Tablet, 12-count — NDC 73581-113-12 (Billing 73581-0113-12)

by YYBA CORP · 12 TABLET in 1 BOTTLE

This is a package of 12 tablets of PINRID Pyrantel Pamoate 250 mg Tablet from YYBA CORP, marketed since Oct 2025 and currently FDA-listed.

NDC 73581-0113-12
🏷️ FDA NDC (as labeled) 73581-113-12 billing pads the product segment with a zero
This package
Contains12-count Pack sizes4 compare ↓
Product page 73581-0113-01 Also comes in: 1 tablet 73581-113-01 6 tablets 73581-113-06 24 tablets 73581-113-24
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73581-113-12 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73581 labeler · 113 product · 12 package
Package marketed since
Oct 1, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC)
0373581105120, 0373581000463, 0373581105243
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73581-113-12
Product NDC 73581-113
11-digit billing NDC 73581011312
RxCUI 668538
UNII 81BK194Z5M
UPC 0373581105120, 0373581000463, 0373581105243
Application # M024
SPL Set ID 59da86a4-db0d-4551-9128-e09a4e85cd78
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-10-01
Route ORAL
Dosage form TABLET
Substance PYRANTEL PAMOATE
Quick answers
  • RxCUI (RxNorm): 668538
Why two NDCs? The FDA registers this code as 73581-113-12 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73581-0113-12. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Tetrahydropyrimidine derivatives class.

Drug family (ATC) Tetrahydropyrimidine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • Pyrantel treats pinworm infections. Pinworms are small parasites that live in the intestines and are especially common in school-age children. If you or your child has been diagnos...
  • Nope — you can take it any time of day, with or without food. Tablets may be taken with milk or fruit juice if that helps. If you're using the liquid suspension, give the bottle a...
  • How do I take it — do I need to take it with food?
  • Yes, in most cases. Pinworms spread easily within a household, so the guidance is to treat everyone in the home at the same time — unless your doctor advises otherwise. This helps...
📖 Read our full Pyrantel guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1 tablet 6 tablets 24 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73581-0113-01 73581-113-01 Main listing 1 TABLET in 1 BOTTLE 2025-12-01 — Active
73581-0113-06 73581-113-06 6 TABLET in 1 BOTTLE 2025-10-01 — Active
73581-0113-12 You're viewing this 12 TABLET in 1 BOTTLE 2025-10-01 — Active
73581-0113-24 73581-113-24 24 TABLET in 1 BOTTLE 2025-10-01 — Active

You're viewing one of 4 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 12-count package — 12 tablet in 1 bottle.
How does this package differ from NDC 73581-0113-01?
Both are PINRID Pyrantel Pamoate 250 mg Tablet — the drug itself is identical. This page's package is the 12-count one, while NDC 73581-0113-01 is the 1 tablet package.
What NDC number is used to bill for this package of PINRID Pyrantel Pamoate 250 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pinrid 250 mg 73581-0111-12 YYBA 12 tablets — — FDA listed —
Pinrid 250 mg 73581-0112-12 YYBA 12 tablets — — FDA listed —
Pinrid 250 mgthis 73581-0113-12 YYBA 12 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Oct 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
ShapeRound
ImprintPR1
Size16 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Pyrantel inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII U725QWY32X
    Povidone K30 is a synthetic polymer made from petroleum. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in the stomach so the medicine can be absorbed.
  • UNII FST467XS7D
    Saccharin is an artificial sweetener derived from benzoic sulfinilanide. It's added to medicines to improve taste and make them easier to take, especially in liquid or chewable formulations.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII H8AV0SQX4D
    A modified starch derived from potato or corn starch. It absorbs water quickly and helps tablets or capsules break apart and dissolve in the stomach, acting as a disintegrant to ensure the medicine releases its active ingredients properly.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAerosil 200, Bubble Gum Flavor, Dextrose, Dicalcium Phosphate, Magnesium Stearate, PVP K30, Saccharine, Sodium Starch Glycolate, Steric Acid, Sucralose, Talc.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerYYBA CORP
FDA applicationM024 (OTC MONOGRAPH DRUG)
Labeler code73581
First marketedOct 2025
Product typeHuman Otc Drug
Portfolio78 products on file

More NDCs from YYBA CORP labeler code 73581

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 7 words ▾

Use for the treatment of pinworm infection

⏱️ Dosage and Administration 82 words ▾

Directions Important- treat the entire household do not repeat treatment unless directed by a doctor take only one dose unless directed by doctor if signs of pinworms persist, see a doctor for children less than 25 pounds or under 2 years old, consult a doctor before use. Weight Dosage 25-37 lb ½ tablet 38-62 lbs 1 tablets 63-87 lbs 1½ tablets 88-112 lbs 2 tablets 113-137 lbs 2½ tablets 138-162 lbs 3 tablets 163-187 lbs 3½ tablets over 188 lbs 4 tablets

⚠️ Warnings 71 words ▾

Warnings Do not exceed recommended dosage. If any of these conditions persist, consult a doctor• dizziness • diarhea • abdominal cramps • vomiting • nausea • headache Keep out of reach of children. In case of overdose, get medical help or contact a poison control center (1-800-222-1222) right away. If pregnant, breast-feeding, or if you have liver disease, ask a doctor before use. Contact your doctor if an allergic reaction occurs.

🧪 Active Ingredient 16 words ▾

Active Ingredient (in each chewable tablet) Pyrantel pamoate 720.5 mg (equivalent to 250 mg pyrantel base)

🧪 Inactive Ingredients 22 words ▾

Intactive ingredients Aerosil 200, Bubble Gum Flavor, Dextrose, Dicalcium Phosphate, Magnesium Stearate, PVP K30, Saccharine, Sodium Starch Glycolate, Steric Acid, Sucralose, Talc.

🎯 Purpose 2 words ▾

Purpose Anthelmintic

🤰 If Pregnant or Breast-Feeding 22 words ▾

If pregnant, breast-feeding, or if you have liver disease, ask a doctor before use. Contact your doctor if an allergic reaction occurs.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a poison control center (1-800-222-1222) right away.

📄 Other Information 24 words ▾

Other information: Store at 15°-30°C (59° - 86 °F) Protect from moisture and heat each tablet contains: calcium 25 mg and phosphorus 20 mg

📄 Questions or Comments 7 words ▾

Questions or comments? call toll free 1-866-474-6743

📄 Package Label / Principal Display Panel 18 words ▾

PRINCIPAL DISPLAY PANEL-6 Counts 1 2

PRINCIPAL DISPLAY PANEL-12 Counts 3 4

PRINCIPAL DISPLAY PANEL-24 Counts 5 6

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for PINRID (this brand).

Top reported reactions

Adverse Event17
Enterobiasis4
Headache3
Treatment Failure3
Helminthic Infection2
Accident At Work1
Accidental Overdose1

Age at onset

Child1
Adolescent1
Adult4

Reporter sex

42 reports
Male · 33%
Female · 57%
Unknown · 10%

Serious outcomes

Hospitalization2
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 24 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by YYBA CORP. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1 tablet (73581-0113-01), 6 tablets (73581-0113-06), 24 tablets (73581-0113-24). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
YYBA CORP is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73581-0112-12 · YYBA 73581-0114-01 · YYBA →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.